<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04911244</url>
  </required_header>
  <id_info>
    <org_study_id>VAP diagnosis</org_study_id>
    <nct_id>NCT04911244</nct_id>
  </id_info>
  <brief_title>Diagnostic Modalities for VAP Detection</brief_title>
  <official_title>Assessment of Different Diagnostic Modalities for Detection of Ventilator Associated Pneumonia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      asses diagnostic performance of different methods for detection of ventilator associated&#xD;
      pneumonia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ventilator associated pneumonia (VAP) is a common cause of nosocomial infection, that can&#xD;
      complicate mechanical ventilation and is related to significant utilization of health-care&#xD;
      resources.&#xD;
&#xD;
      The diagnosis of VAP is subjected to considerable interobserver variability. The Centers for&#xD;
      Disease Control and Prevention (CDC) definition of VAP uses a combination of clinical,&#xD;
      radiographic, and micro-biological criteria for diagnosis, but in the absence of a definite&#xD;
      diagnostic test, the accurate diagnosis and treatment of VAP is limited.&#xD;
&#xD;
      The clinical pulmonary infection score (CPIS) was developed to objectively diagnose VAP and&#xD;
      assign points on the basis of clinical and radiographic data, but its role in diagnosing&#xD;
      pneumonia remains controversial .&#xD;
&#xD;
      Lung ultrasound (LUS) is a simple, non irradiating, noninvasive, cost-effective, bedside&#xD;
      technique. It has been successfully applied for monitoring aeration and monitoring antibiotic&#xD;
      efficacy in ventilator-associated pneumonia (VAP). However, no scientific evidence is yet&#xD;
      available on whether LUS reliably improves the diagnosis of VAP.&#xD;
&#xD;
      Quantitative bacterial cultures of the specimen obtained from the lower airways using&#xD;
      bronchoscope were proposed for VAP diagnosis with a cut off value of 104 colony-forming&#xD;
      unit/ml. However, microbiological cultures cannot guide the early clinical management of&#xD;
      patients with a suspected VAP, as they need at least 24 hours for preliminary results. So,&#xD;
      starting antibiotics remains a challenge. Moreover, bronchoscopy is not always easy to&#xD;
      perform in hypoxemic patients and not promptly available in all ICUs. Therefore, it can be&#xD;
      replaced by tracheal aspirate microbiological samples.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2016</start_date>
  <completion_date type="Actual">February 2020</completion_date>
  <primary_completion_date type="Actual">October 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
  </study_design_info>
  <primary_outcome>
    <measure>To detected diagnostic accuracy of chest ultrasound in VAP.</measure>
    <time_frame>3 years</time_frame>
    <description>To identify sensitivity and specificity of chest ultrasound in VAP diagnosis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To detected diagnostic accuracy of protected endotracheal aspirate in VAP.</measure>
    <time_frame>3 years</time_frame>
    <description>To identify sensitivity and specificity of protected endotracheal aspirate in VAP diagnosis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To detected diagnostic accuracy of usual endotracheal aspirate in VAP.</measure>
    <time_frame>3 years</time_frame>
    <description>To identify sensitivity and specificity of usual endotracheal aspirate in VAP diagnosis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To detected diagnostic accuracy of chest X-ray in VAP.</measure>
    <time_frame>3 years</time_frame>
    <description>To identify sensitivity and specificity of chest X-ray in VAP diagnosis</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Ventilator Associated Pneumonia</condition>
  <arm_group>
    <arm_group_label>VAP group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients confirmed diagnosis of VAP with bronchoalveolar lavage</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non VAP group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients confirmed not VAP with bronchoalveolar lavage</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>bronchoalveolar lavage</intervention_name>
    <description>endobronchial sampling through bronchoscopy</description>
    <arm_group_label>Non VAP group</arm_group_label>
    <arm_group_label>VAP group</arm_group_label>
    <other_name>protected endotracheal aspirate</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All adult patients mechanically ventilated for at least 48 hours in Respiratory ICU&#xD;
             were included in the study.&#xD;
&#xD;
        who had:&#xD;
&#xD;
          -  Clinically suspected VAP according to simplified Clinical Pulmonary Infectious Score&#xD;
             exceeding 6.&#xD;
&#xD;
          -  Or new or extension of a radiological image with at least two of the following&#xD;
             clinical criteria:&#xD;
&#xD;
               -  Body temperature ≥ 38.5 ° C or &lt;36 ° C.&#xD;
&#xD;
               -  Leukocytes&gt; 10 * 103 / ml or &lt;4 * 103/ ml or &gt; 10% immature cells (in the absence&#xD;
                  of other known causes).&#xD;
&#xD;
               -  Purulent tracheal secretions.&#xD;
&#xD;
               -  Hypoxemia with PaO2 &lt;60 mmHg or a PaO2 / FiO2 &lt;300.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with diagnosis of community acquired pneumonia or hospital acquired pneumonia&#xD;
             before starting of mechanical ventilation.&#xD;
&#xD;
          -  Patients who are contraindicated for bronchoscopy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <reference>
    <citation>Nair GB, Niederman MS. Ventilator-associated pneumonia: present understanding and ongoing debates. Intensive Care Med. 2015 Jan;41(1):34-48. doi: 10.1007/s00134-014-3564-5. Epub 2014 Nov 27. Review.</citation>
    <PMID>25427866</PMID>
  </reference>
  <reference>
    <citation>Bouhemad B, Liu ZH, Arbelot C, Zhang M, Ferarri F, Le-Guen M, Girard M, Lu Q, Rouby JJ. Ultrasound assessment of antibiotic-induced pulmonary reaeration in ventilator-associated pneumonia. Crit Care Med. 2010 Jan;38(1):84-92. doi: 10.1097/CCM.0b013e3181b08cdb.</citation>
    <PMID>19633538</PMID>
  </reference>
  <reference>
    <citation>Mongodi S, Via G, Girard M, Rouquette I, Misset B, Braschi A, Mojoli F, Bouhemad B. Lung Ultrasound for Early Diagnosis of Ventilator-Associated Pneumonia. Chest. 2016 Apr;149(4):969-80. doi: 10.1016/j.chest.2015.12.012. Epub 2015 Dec 22.</citation>
    <PMID>26836896</PMID>
  </reference>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 24, 2021</study_first_submitted>
  <study_first_submitted_qc>May 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 2, 2021</study_first_posted>
  <last_update_submitted>May 30, 2021</last_update_submitted>
  <last_update_submitted_qc>May 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Sahar Refaat Mahmoud</investigator_full_name>
    <investigator_title>Principle investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Pneumonia, Ventilator-Associated</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

